COVID-19 has offered a unique opportunity for India to re-charge its "Make in India" mantra. For example, the current dependency of Indian pharma companies on Chinese APIs has prompted the government to review the country's situation in the API sector.

Likewise, COVID-19 is playing a catalytic role by enabling India's best innovative minds to develop solutions towards easing the healthcare community pressure and help save lives. Perhaps it is time for India to emerge as a leader in the life sciences sector.

But the bigger Question is how to make it happen. And to get answers to this, we have the experts right here with us.

• Dr Satya Prakash Dash, Founding & Former Head of Strategy,
  Partnerships & Entrepreneurship Development, Biotechnology Industry Research Assistance Council (BIRAC)
• Praveen Gupta, Managing Director, Premas Life Sciences, Gurugram
• Dr Prabuddha Kundu, Co-founder & Managing Director, Premas Biotech, Gurugram
• Dr Rakesh Mishra, Director, Centre for Cellular & Molecular Biology (CCMB), Hyderabad
• Dr. Renu John, Professor & Head of the Department, Biomedical Engineering, Indian Institute of Technology (IIT), Hyderabad

Watch our latest webinar video to get all the answers